{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:31Z","timestamp":1760060071503,"version":"build-2065373602"},"reference-count":49,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Membranous nephropathy (MN) is the most prevalent cause of nephrotic syndrome (NS) in adults, and it can be primary (idiopathic) with an unknown cause or secondary due to a variety of conditions (lupus, infections, malignancies, medications, etc.). It progresses to chronic kidney disease (CKD) in up to 60% of patients, and 10 to 30% develop end-stage kidney disease (ESKD). This retrospective study examines the importance of specific factors, including baseline demographic and clinical data, kidney biopsy PH findings, and selected biochemical parameters, influencing MN outcomes after 10 years of follow-up. The cohort included 94 individuals in whom a diagnosis of MN was established by percutaneous biopsy of the left kidney\u2019s lower pole at the University Clinical Center of Serbia (UCCS) between 2008 and 2013. According to the outcomes, patients were divided into three groups: the recovery (Rec) group, with complete remission, including normal serum creatinine (Scr) and proteinuria (Prt), the group with development of chronic kidney disease (CKD), and the group with development of end-stage kidney disease (ESKD). Nephropathologists graded pathohistological (PH) results from I to III based on the observed PH findings. During the follow-up period, 33 patients were in the Rec group, CKD developed in 53 patients, and ESKD developed in 8 patients. Baseline creatinine clearance levels (Ccr), Scr, and uric acid (urate) were found to be significantly associated with the outcomes (p &lt; 0.001). The lowest values of baseline Scr and urate were observed in the Rec group. The presence of acute kidney injury (AKI) or CKD at the time of kidney biopsy was associated with the more frequent development of ESKD (p = 0.02). Lower Ccr was associated with a higher likelihood of progressing to CKD (B = \u22120.021, p = 0.014), whereas older age independently predicted progression to ESKD (B = 0.02, p = 0.032). Based on this study, it was concluded that the most important biochemical and clinical factors that are associated with the outcomes of this disease are the values of Scr, Ccr, and urate and the existence of CKD at the time of kidney biopsy. Unlike most previous studies, the presence of HTN had no statistical significance in the outcome of the disease.<\/jats:p>","DOI":"10.3390\/life15081221","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T09:41:17Z","timestamp":1754300477000},"page":"1221","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory, Clinical, and Pathohistological Significance of the Outcomes of Patients with Membranous Nephropathy After 10 Year of Follow-Up"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5585-9793","authenticated-orcid":false,"given":"Marko","family":"Barali\u0107","sequence":"first","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-261X","authenticated-orcid":false,"given":"Selena","family":"Gaji\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihajlo","family":"Kosti\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-6961","authenticated-orcid":false,"given":"Milorad","family":"Stojadinovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Fili\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danka","family":"Bjeli\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3744-1819","authenticated-orcid":false,"given":"Vidna","family":"Karad\u017ei\u0107-Ristanovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6174-0932","authenticated-orcid":false,"given":"Ivana","family":"Mr\u0111a","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovana","family":"Gavrilovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-3850","authenticated-orcid":false,"given":"Danica","family":"\u0106uji\u0107","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9093-6998","authenticated-orcid":false,"given":"Aleksandar","family":"Si\u010d","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Jankovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Putica","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-535X","authenticated-orcid":false,"given":"Sanja","family":"Stankovic","sequence":"additional","affiliation":[{"name":"Center for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u0161an","family":"Vi\u0107entijevi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"\u017divoti\u0107","sequence":"additional","affiliation":[{"name":"Institute of Pathology \u201cDr. \u0110or\u0111e Jovanovi\u0107\u201d, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Radojevi\u0107-\u0160kodri\u0107","sequence":"additional","affiliation":[{"name":"Institute of Pathology \u201cDr. \u0110or\u0111e Jovanovi\u0107\u201d, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Pavlovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Bonti\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kezi\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","article-title":"Primary membranous nephropathy: Comprehensive review and historical perspective","volume":"95","author":"Keri","year":"2019","journal-title":"Postgrad. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary Membranous Nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/gene.2014.50","article-title":"PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes","volume":"15","author":"Saeed","year":"2014","journal-title":"Genes Immun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","article-title":"Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway","volume":"45","author":"Miao","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"StanStanescu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bph.16219","article-title":"Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites","volume":"181","author":"Miao","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000533537","article-title":"Altered Intestinal Microbial Flora and Metabolism in Patients with Idiopathic Membranous Nephropathy","volume":"54","author":"Shi","year":"2023","journal-title":"Am. J. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A Proposal for a Serology-Based Approach to Membranous Nephropathy","volume":"28","author":"Glassock","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000520399","article-title":"Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection","volume":"11","author":"Baker","year":"2021","journal-title":"Case Rep. Nephrol. Dial."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhang, X.D., Cui, Z., Zhang, M.F., Wang, J., Zhang, Y.M., Qu, Z., Wang, X., Huang, J., Wang, F., and Meng, L.Q. (2018). Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1011-5"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.kint.2018.12.018","article-title":"Health-related quality of life in glomerular disease","volume":"95","author":"Canetta","year":"2019","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ekir.2020.12.035","article-title":"RITERM study group. Rituximab in Membranous Nephropathy","volume":"6","author":"Gauckler","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/ndt\/gfad227","article-title":"Membranous nephropathy-diagnosis and identification of target antigens","volume":"39","author":"Sethi","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ndt\/gfw404","article-title":"Membranous nephropathy: Thinking through the therapeutic options","volume":"32","author":"Cattran","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ponticelli, C. (2025). Membranous Nephropathy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030761"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Park, J., Kim, H.-J., Kim, J., Choi, Y.-B., Shin, Y.-S., and Lee, M.-J. (2020). Predictive value of serum albumin-to-globulin ratio for incident chronic kidney disease: A 12-year community-based prospective study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238421"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/his.13955","article-title":"Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients","volume":"75","author":"Stangou","year":"2019","journal-title":"Histopathology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"28","author":"Seifert","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1681\/ASN.2021101384","article-title":"Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy","volume":"33","author":"Gao","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Oh, J.E., and Lee, H.K. (2014). Pattern Recognition Receptors and Autophagy. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00300"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40620-015-0234-9","article-title":"Glomerular diseases and cancer: Evaluation Glomerular diseases and cancer: Evaluation of underlying malignancy","volume":"29","author":"Pani","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/1440-1681.12878","article-title":"Reduced tubular degradation of glomerular filtered plasma albumin is a common feature in acute and chronic kidney disease","volume":"45","author":"Han","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How Does Proteinuria Cause Progressive Renal Damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1152\/ajprenal.00125.2016","article-title":"Proteinuria causes dysfunctional autophagy in the proximal tubule","volume":"311","author":"Nolin","year":"2016","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.kint.2020.07.027","article-title":"Kidney-derived PCSK9-a new driver of hyperlipidemia in nephrotic syndrome?","volume":"98","author":"Artunc","year":"2020","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Teisseyre, M., Cremoni, M., Boyer-Suavet, S., Ruetsch, C., Gra\u00e7a, D., Esnault, V.-L.-M., Brglez, V., and Seitz-Polski, B. (2022). Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.859419"},{"key":"ref_32","first-page":"229","article-title":"Membranous nephropathy","volume":"45","author":"Dantas","year":"2023","journal-title":"J. Bras. Nefrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e39708","DOI":"10.1097\/MD.0000000000039708","article-title":"Mendelian study on air pollution and membranous nephropathy outcomes associations","volume":"103","author":"Zhu","year":"2024","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2215\/CJN.05310513","article-title":"HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy","volume":"9","author":"Bullich","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.25259\/ijn_317_23","article-title":"An Updated Review of Membranous Nephropathy","volume":"34","author":"Efe","year":"2024","journal-title":"Indian. J. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Storrar, J., Gill-Taylor, T., Chinnadurai, R., Chrysochou, C., Poulikakos, D., Rainone, F., Ritchie, J., Lamerton, E., Kalra, P.A., and Sinha, S. (2022). A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0276053"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5414\/CN107681","article-title":"Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population","volume":"79","author":"Zuo","year":"2013","journal-title":"Clin. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/ndt\/gfv435","article-title":"Long-term outcomes of persistent disease and relapse in primary membranous nephropathy","volume":"31","author":"Kanigicherla","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.ki.5000289","article-title":"Renal pathology in idiopathic membranous nephropathy: A new perspective","volume":"69","author":"Troyanov","year":"2006","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e172976","DOI":"10.1172\/jci.insight.172976","article-title":"C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy","volume":"9","author":"Zhang","year":"2024","journal-title":"JCI Insight"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ndt\/gfad225","article-title":"Membranous nephropathy treatment standard","volume":"39","author":"Radhakrishnan","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12986-022-00701-4","article-title":"High-coverage targeted lipidomics could reveal lipid alterations and evaluate therapeutic efficacy of membranous nephropathy","volume":"19","author":"Lu","year":"2022","journal-title":"Nutr. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40620-016-0278-5","article-title":"Lipotoxicity as a trigger factor of renal disease","volume":"29","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bisgaard, L.S., and Christoffersen, C. (2021). The apoM\/S1P Complex-A Mediator in Kidney Biology and Disease?. Front. Med., 8.","DOI":"10.3389\/fmed.2021.754490"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/phar.1575","article-title":"Overview of current and alternative therapies for idiopathic membranous nephropathy","volume":"35","author":"Tran","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s11255-019-02254-7","article-title":"Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy","volume":"51","author":"Zhang","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Choi, J.Y., Chin, H.J., Lee, H., Bae, E.H., Chang, T.I., Lim, J.H., Jung, H.Y., Cho, J.H., Kim, C.D., and Kim, Y.L. (2020). Idiopathic membranous nephropathy in older patients: Clinical features and outcomes. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0240566"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000527368","article-title":"Diagnosis and Course of Membranous Nephropathy in Adults: Comparison by Age Group","volume":"47","author":"Paulo","year":"2022","journal-title":"Kidney Blood Press. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.archger.2018.03.002","article-title":"Treatment and clinical outcomes of elderly idiopathic membranous nephropathy: A multicenter cohort study in Korea","volume":"76","author":"Bae","year":"2018","journal-title":"Arch. Gerontol. Geriatr."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/8\/1221\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:39Z","timestamp":1760034099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/8\/1221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["life15081221"],"URL":"https:\/\/doi.org\/10.3390\/life15081221","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}